The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Postpubertal Emergence of Hyperresponsiveness to Stress and to Amphetamine after Neonatal Excitotoxic Hippocampal Damage: A Potential Animal Model of Schizophrenia
Abstract
The constellation of major phenomena associated with schizophrenia (e.g., postpubertal onset, congenital hippocampal area damage, cortical functional deficits, limbic dopamine (DA) dysregulation, and vulnerability to stress) have been difficult to explain with a unitary animal model. Although it has been shown that rats develop increased mesolimbic DA transmission and reduced cortical DA turnover following adult excitotoxic lesions of the ventral hippocampus (VH), the implications of early developmental VH lesions are not known. To determine the developmental sequelae of such changes, we produced ibotenic acid lesions of the ventral hippocampal formation in rats on the 7th day after birth (PD7). Motor activity in a novel environment, after saline injection and after d-amphetamine administration were similar in control and lesioned rats at PD35. However, in early adulthood, at PD56, animals with the hippocampal lesion were hyperactive in each of these conditions. The emergence of the hyperactivity at PD56 could be prevented by pretreatment with haloperidol. Moreover, rats lesioned as neonates, in contrast to a similar lesion induced in adult animals, were also hyperresponsive to stress evaluated with a swim test. This latter effect is analogous to that seen after adult lesions of the medial prefrontal cortex, rather than after adult lesions of VH, suggesting that the neonatal VH lesion may affect functional development of the medial prefrontal cortex. These results demonstrate…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These are primarily based on pharmacological lesions of the developing hippocampus, such as the prenatal exposure to methylazoxymethanol acetate (MAM) and the neonatal ventral hippocampal lesion (NVHL) models 55,56 .”
From Developmental timing and critical windows for the treatment of psychiatric disorders (2016) · cites this paper as [55]
In the citing paper
“Both models reproduce some of the defects observed in schizophrenia, including functional deficits in PV+ fast spiking interneurons.”
From Developmental timing and critical windows for the treatment of psychiatric disorders (2016) · cites this paper as [55]
Citations
Cites
Dopamine in schizophrenia: a review and reconceptualization
Davis, K. L., Kahn, R. S., Ko, G., & Davidson, M. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1474 · Cited by 2,051
Factors That Predict Individual Vulnerability to Amphetamine Self-Administration
Piazza, P. V., Deminière, J.-M., Moal, M. L., & Simon, H. (1989) · Science · doi:10.1126/science.2781295 · Cited by 1,355
Bogerts, B. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790310046006 · Cited by 880
Groenewegen, H. J., Vermeulen‐Vanderzee, E., Kortschot, A. T., & Witter, M. P. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90275-2 · Cited by 867
Goldman‐Rakic, P. S., Selemon, L. D., & Schwartz, M. L. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90166-0 · Cited by 782
Kelley, A. E., & Domesick, V. B. (1982) · Neuroscience · doi:10.1016/0306-4522(82)90198-1 · Cited by 746
Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats
PYCOCK, C., Kerwin, R. W., & Carter, C. J. (1980) · Nature · doi:10.1038/286074a0 · Cited by 550
Development of the dopaminergic innervation in the prefrontal cortex of the rat
Kalsbeek, A., Voorn, P., Buijs, R. M., Pool, C. W., & Uylings, H. B. M. (1988) · Journal of Comparative Neurology · doi:10.1002/cne.902690105 · Cited by 545
Cerebral Glucography With Positron Tomography
Buchsbaum, M. S. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290030001001 · Cited by 535
Sesack, S. R., & Pickel, V. M. (1990) · Brain Research · doi:10.1016/0006-8993(90)91146-8 · Cited by 439
Flagged first, then by citations
1 of the 34 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 697
Electrophysiological Endophenotypes in Rodent Models of Schizophrenia and Psychosis
Rosen, A. M., Spellman, T., & Gordon, J. A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.03.021 · Cited by 37
Weiner, I., & Joel, D. (2002) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06765-9_13 · Cited by 37
Insights on current and novel antipsychotic mechanisms from the MAM model of schizophrenia
Sonnenschein, S. F., & Grace, A. A. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.05.009 · Cited by 37
New perspectives on schizotypal personality disorder
Kirrane, R., & Siever, L. (2000) · Current Psychiatry Reports · doi:10.1007/s11920-000-0044-0 · Cited by 27
Simpson, S. M., Menard, J. L., Reynolds, J. N., & Beninger, R. J. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.12.008 · Cited by 35
Johnson, S. L. M., Wang, L., Alpert, K. I., GREENSTEIN, D. K., CLASEN, L. S., Lalonde, F. M., Miller, R., Rapoport, J. L., & Gogtay, N. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.02.003 · Cited by 36
Sabaroedin, K., Tiego, J., & Fornito, A. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.07.017 · Cited by 33
Overview of Animal Models of Schizophrenia
Powell, S. B., & Geyer, M. A. (2007) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0924s39 · Cited by 35
Behavioral and Molecular Biomarkers in Translational Animal Models for Neuropsychiatric Disorders
Sarnyai, Z., Alsaif, M., Bahn, S., Ernst, A., Guest, P. C., Hradetzky, E., Kluge, W. F., Stelzhammer, V., & Wesseling, H. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-387718-5.00008-0 · Cited by 35
Anoxia at birth induced hyperresponsiveness to amphetamine and stress in postpubertal rats
Juárez, I., Gómez, A. B. S., Peralta, F., & Flores, G. (2003) · Brain Research · doi:10.1016/j.brainres.2003.08.060 · Cited by 35
Brooks, J. M., Sarter, M. F., & Bruno, J. P. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.006 · Cited by 35
Vercauteren, F., Flores, G., Ma, W., Chabot, J., Geenen, L., Clerens, S., Fazel, A., Bergeron, J. J. M., Srivastava, L. K., Arckens, L., et al. (2007) · PROTEOMICS · doi:10.1002/pmic.200700379 · Cited by 35
Chrapusta, S. J., Egan, M. F., Wyatt, R. J., Weinberger, D. R., & Lipska, B. K. (2003) · Synapse · doi:10.1002/syn.10179 · Cited by 36
Self-citationThe effect of perinatal brain injury on dopaminergic function and hippocampal volume in adult life
Froudist‐Walsh, S., Bloomfield, M., Veronese, M., Kroll, J., Karolis, V. R., Jauhar, S., Bonoldi, I., McGuire, P. K., Kapur, S., Murray, R. M., et al. (2017) · eLife · doi:10.7554/elife.29088 · Cited by 36
Tendilla‐Beltrán, H., Sanchez-Islas, N. D. C., Marina-Ramos, M., Leza, J. C., & Flores, G. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101967 · Cited by 36
Park, M. T. M., Jeon, P., KHAN, A. R., Dempster, K., Chakravarty, M. M., Lerch, J. P., Mackinley, M., Théberge, J., & Palaniyappan, L. K. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110297 · Cited by 33
Social memory is impaired in neonatally ibotenic acid lesioned rats
Becker, A., & Grecksch, G. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00163-1 · Cited by 34
Behavioral Phenotypes for Negative Symptoms in Animal Models of Schizophrenia
Miyamoto, Y., & Nitta, A. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.14r02cr · Cited by 32
Schizophrenia: an integrative approach to modelling a complex disorder
Robertson, G. S., Hori, S. E., & Powell, K. J. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0619 · Cited by 34
Prepulse inhibition mechanisms and cognitive processes: a review and model
Larrauri, J., & Schmajuk, N. A. (2006) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7772-4_12 · Cited by 32
Black, M. D., Simmonds, J., Senyah, Y., & Wettstein, J. G. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00180-0 · Cited by 33
Nadri, C., Lipska, B. K., Kozlovsky, N., Weinberger, D. R., Belmaker, R. H., & Agam, G. (2003) · Developmental Brain Research · doi:10.1016/s0165-3806(02)00639-9 · Cited by 33
Self-citationGABA Transporter-1 Deficiency Confers Schizophrenia-Like Behavioral Phenotypes
Yu, Z., Fang, Q., Xiao, X., Wang, Y., Cai, Y.-Q., Cao, H., Hu, G., Chen, Z., Fei, J., Gong, N., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069883 · Cited by 34
Uliana, D. L., Zhu, X., Gomes, F. V., & Grace, A. A. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.935320 · Cited by 36
Lazar, N. L., Rajakumar, N., & Cain, D. P. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm039 · Cited by 32
Black, M. D., Lister, S., Hitchcock, J. M., van Giersbergen, P., & Sorensen, S. M. (1998) · Drug Development Research · doi:10.1002/(sici)1098-2299(199804)43:4 · Cited by 32
Sensory and Sensorimotor Gating Deficits after Neonatal Ventral Hippocampal Lesions in Rats
Swerdlow, N. R., Light, G. A., Breier, M. R., Shoemaker, J. M., Marie, R. L. S., Neary, A. C., Geyer, M. A., Stevens, K. E., & Powell, S. B. (2012) · Developmental Neuroscience · doi:10.1159/000336841 · Cited by 31
Vázquez‐Roque, R. A., Ubhi, K. K., Masliah, E., & Flores, G. (2013) · Synapse · doi:10.1002/syn.21718 · Cited by 32
Cortical gene expression in the neonatal ventral-hippocampal lesion rat model
Wong, A. H. C., Lipska, B. K., Likhodi, O., Boffa, E., Weinberger, D. R., Kennedy, J. L., & Tol, H. H. M. V. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.03.011 · Cited by 31
Self-citationSolís, Ó., Vázquez‐Roque, R. A., Camacho‐Abrego, I., Gamboa, C., de la Cruz, F., Zamudio, S., & Flores, G. (2009) · Synapse · doi:10.1002/syn.20697 · Cited by 32
Animal Models of Schizophrenia
Yanagi, M., Southcott, S. A., Lister, J. M., & Tamminga, C. A. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394596-9.00012-3 · Cited by 32
Noradrenaline involvement in basic and higher integrated REM sleep processes
Gottesmann, C. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.04.002 · Cited by 33
Steckler, T., & Holsboer, F. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00003-0 · Cited by 31
Endo, K., Hori, T., Abe, S., & Asada, T. (2007) · Synapse · doi:10.1002/syn.20393 · Cited by 33
Laplante, F., Lappi, D. A., & Sullivan, R. M. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.12.005 · Cited by 30
Serotonin and dopamine interactions in psychosis prevention
Richtand, N. M., & McNamara, R. K. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00907-2 · Cited by 28
Negrete‐Díaz, J. V., Baltazar‐Gaytán, E., Bringas, M. E., Vázquez‐Roque, R. A., Newton, S., Aguilar‐Alonso, P., León‐Chávez, B. A., & Flores, G. (2010) · Synapse · doi:10.1002/syn.20835 · Cited by 30
Neural and neuronal discoordination in schizophrenia: from ensembles through networks to symptoms
Krajcovic, B., Fajnerova, I., Horacek, J., Kelemen, E., Kubik, S., Svoboda, J., & Stuchlik, A. (2019) · Acta Physiologica · doi:10.1111/apha.13282 · Cited by 29
Post‐pubertal emergence of a dopamine phenotype in netrin‐1 receptor‐deficient mice
Grant, A., Speed, Z., Labelle‐Dumais, C., & Flores, C. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06919.x · Cited by 29
Chambers, R. A., Jones, R., Brown, S. D., & Taylor, J. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2042-0 · Cited by 27
Vargas, J. P., Díaz, E., Portavella, M., & López, J. C. (2016) · Frontiers in Psychology · doi:10.3389/fpsyg.2016.00206 · Cited by 28
Stine, C. D. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00212-8 · Cited by 29
Pain sensitivity is altered in animals after subchronic ketamine treatment
Becker, A., Grecksch, G., & Schröder, H. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0557-2 · Cited by 29
Stevens, K. E., Nagamoto, H. T., Johnson, R. G., Adams, C. E., & Rose, G. M. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00299-6 · Cited by 29
Wood, G. K., Quirion, R., & Srivastava, L. K. (2003) · Synapse · doi:10.1002/syn.10265 · Cited by 31
Velakoulis, D., Wood, S. J., McGorry, P. D., & Pantelis, C. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2000.00788.x · Cited by 29
Yabuki, Y., Wu, L., & Fukunaga, K. (2019) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2019.07.015 · Cited by 27
Season of birth in schizophrenia: a maternal-fetal chronobiological hypothesis.
Schwartz, P. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.02.019 · Cited by 32
Morales‐Medina, J. C., Mejorada, A., Romero‐Curiel, A., & Flores, G. (2007) · Synapse · doi:10.1002/syn.20406 · Cited by 28
Chambers, R. A. (2009) · Journal of Dual Diagnosis · doi:10.1080/15504260902869808 · Cited by 28
Challenges for translational psychopharmacology research—some basic principles
Miczek, K. A., & de Wit, H. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1198-4 · Cited by 29
Electroencephalographic activity in neonatal ventral hippocampus lesion in adult rats
Valdés‐Cruz, A., Negrete‐Díaz, J. V., Magdaleno-Madrigal, V. M., Martı́nez-Vargas, D., Fernández‐Mas, R., Almazán‐Alvarado, S., García, M. E. T., & Flores, G. (2012) · Synapse · doi:10.1002/syn.21563 · Cited by 28
Developing New Drugs for Schizophrenia: From Animals to the Clinic
Jones, D. N. C., Gartlon, J. E., Minassian, A., Perry, W., & Geyer, M. A. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00008-4 · Cited by 30
Neonatal lesions of the left entorhinal cortex affect dopamine metabolism in the rat brain
Uehara, T., Tanii, Y., Sumiyoshi, T., & Kurachi, M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)01985-5 · Cited by 28
Choi, C. S., Hong, M., Kim, K. C., Kim, J., Yang, S. M., Seung, H., Ko, M. J., Choi, D., You, J. S., Shin, C. Y., et al. (2014) · Biomolecules & Therapeutics · doi:10.4062/biomolther.10.4062/biomolther.2014.027 · Cited by 30
Melatonin in Neurodevelopmental Disorders: A Critical Literature Review
Feybesse, C., Sylvie Chokron, A., & Tordjman, S. (2023) · Antioxidants · doi:10.3390/antiox12112017 · Cited by 29
Ando, N., Morimoto, K., Watanabe, T., Ninomiya, T., & Suwaki, H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300427 · Cited by 27
Alcohol seeking and consumption in the NVHL neurodevelopmental rat model of schizophrenia
Berg, S. A., Czachowski, C. L., & Chambers, R. A. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.12.017 · Cited by 26
In Vitro and In Vivo Models for the Investigation of Potential Drugs Against Schizophrenia
Koszła, O., Targowska‐Duda, K. M., Kędzierska, E., & Kaczor, A. A. (2020) · Biomolecules · doi:10.3390/biom10010160 · Cited by 26
Zhang, M., Ballard, M. E., Kohlhaas, K. L., Browman, K. E., Jongen-Rêlo, A.-L., Unger, L., Fox, G. B., Groß, G., Decker, M. W., Drescher, K. U., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300985 · Cited by 26
Lillrank, S. M., Lipska, B. K., Weinberger, D. R., Fredholm, B. B., Fuxé, K., & Ferré, S. (1999) · Neurochemistry International · doi:10.1016/s0197-0186(99)00008-x · Cited by 26
Self-citationPlacek, K., Dippel, W. C., Jones, S., & Brady, A. M. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.08.034 · Cited by 25
The role of executive functions in psychiatric disorders
Testa, R., & Pantelis, C. (2009) · The Neuropsychology of Mental Illness · doi:10.1017/cbo9780511642197.012 · Cited by 25
Trophic factors as potential therapies for treatment of major mental disorders
Dremencov, E., Ježová, D., Barak, S., Gaburjáková, J., Gaburjáková, M., Kútna, V., & Ovsepian, S. V. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136194 · Cited by 25
Grace, A., & Uliana, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512374 · Cited by 26
Marche, K., Danel, T., & Bordet, R. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1960-2 · Cited by 25
Cassidy, A. W., Mulvany, S. K., Pangalos, M. N., Murphy, K. J., & Regan, C. M. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.12.045 · Cited by 26
Marquis, J., Goulet, S.-M., & Doré, F. Y. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.048 · Cited by 27
Zuckerman, L., Rimmerman, N., & Weiner, I. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1460-8 · Cited by 25
Yabuki, Y., Nakagawasai, O., Moriguchi, S., Shioda, N., Onogi, H., Tan–No, K., Tadano, T., & Fukunaga, K. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.12.048 · Cited by 25
Zamudio, S., Quevedo-Corona, L., Garcés, L., & de la Cruz, F. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.09.005 · Cited by 25
Morales‐Medina, J. C., Mejorada, A., Romero‐Curiel, A., Aguilar‐Alonso, P., León‐Chávez, B. A., Gamboa, C., Quirion, R., & Flores, G. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.019 · Cited by 25
Wan, R., Hartman, H. B., & Corbett, R. (1998) · Physiology & Behavior · doi:10.1016/s0031-9384(98)00179-6 · Cited by 25
Chambers, R. A., Sentir, A. M., & Engleman, E. A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1929-1 · Cited by 24
Chambers, R. A., McClintick, J. N., Sentir, A. M., Berg, S. A., Runyan, M., Choi, K. H., & Edenberg, H. J. (2013) · Genes Brain & Behavior · doi:10.1111/gbb.12051 · Cited by 24
The Involvement of Noradrenaline in Rapid Eye Movement Sleep Mentation
Gottesmann, C. (2011) · Frontiers in Neurology · doi:10.3389/fneur.2011.00081 · Cited by 25
Naert, A., Gantois, I., Laeremans, A., Vreysen, S., den Bergh, G. V., Arckens, L., Callaerts‐Vegh, Z., & D’Hooge, R. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.01.008 · Cited by 27
Ryan, R. T., Bhardwaj, S. K., Tse, Y. C., Srivastava, L. K., & Wong, T. P. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs111 · Cited by 26
Young, J. W., Winstanley, C. A., Brady, A. M., & Hall, F. S. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.10.029 · Cited by 28
Neuropathological studies of brain tissue in schizophrenia
Bunney, B. G., Potkin, S. G., & Bunney, W. E. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(96)00038-6 · Cited by 24
Powell, K. J., Binder, T. L., Hori, S. E., Nakabeppu, Y., Weinberger, D. R., Lipska, B. K., & Robertson, G. S. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300883 · Cited by 24
Self-citationLaplante, F., Nakagawasai, O., Srivastava, L. K., & Quirion, R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300640 · Cited by 24
Developmental dysregulation of the dopamine system and the pathophysiology of schizophrenia
Grace, A. A. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511735103.017 · Cited by 24
Developing therapeutics for schizophrenia and other psychotic disorders
Marek, G. J., & Merchant, K. (2005) · NeuroRx · doi:10.1602/neurorx.2.4.579 · Cited by 22
Rajakumar, N., Leung, L.-W. S., Ma, J., Rajakumar, B. S. J., & Rushlow, W. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.12.015 · Cited by 23
Dreaming and schizophrenia: A common neurobiological background
Gottesmann, C. (2005) · Sleep and Biological Rhythms · doi:10.1111/j.1479-8425.2005.00164.x · Cited by 22
Zarate, J. M., Boksa, P., Baptista, T., & Joober, R. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1553-4 · Cited by 23
Plataforma económica para cirugía estereotáxica en rata neonata
Sierra, A., Camacho‐Abrego, I., Escamilla, C., Negrete‐Díaz, J. V., Rodríguez‐Sosa, L., & Flores, G. (2009) · Revista de Neurología · doi:10.33588/rn.4803.2008571 · Cited by 23
Wood, G. K., Marcotte, E. R., Quirion, R., & Srivastava, L. K. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01716.x · Cited by 23
Léna, I., Chessel, A., Pen, G. L., Krebs, M., & Garcia, R. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0719-x · Cited by 23
Simpson, S. M., Hickey, A. J., Baker, G. B., Reynolds, J. N., & Beninger, R. J. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.027 · Cited by 22
Schmadel, S., Schwabe, K., & Koch, M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.011 · Cited by 22
A hyperglycinergic rat model for the pathogenesis of schizophrenia: preliminary findings
Waziri, R., & Baruah, S. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00169-8 · Cited by 22
Kainic acid lesions enhance locomotor responses to novelty, saline, amphetamine, and MK-801
Bardgett, M. E., Jacobs, P. S., Jackson, J. L., & Csernansky, J. G. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(96)00132-5 · Cited by 22
Nagano, T., Mizuno, M., Morita, K., & Nawa, H. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_399 · Cited by 21
Apam-Castillejos, D. J., Tendilla‐Beltrán, H., Vázquez‐Roque, R. A., Vázquez-Hernández, A. J., Fuentes‐Medel, E., García‐Dolores, F., Díaz, A., & Flores, G. (2022) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2022.102166 · Cited by 21
Cortical signal-to-noise ratio: insight into the pathophysiology and genetics of schizophrenia
Winterer, G., & Weinberger, D. R. (2003) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(03)00019-7 · Cited by 21
Self-citationThe Potential of Cerebrolysin in the Treatment of Schizophrenia
Flores, G., & Atzori, M. (2014) · Pharmacology & Pharmacy · doi:10.4236/pp.2014.57079 · Cited by 21
Alexander, K., Brooks, J. M., Sarter, M. F., & Bruno, J. P. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.105 · Cited by 21
Neurodevelopmental insights into circuit dysconnectivity in schizophrenia
Nath, M., Wong, T. P., & Srivastava, L. K. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110047 · Cited by 24
Metadata
- Authors
- Lipska, B. K., Jaskiw, G. E., & Weinberger, D. R.
- Affiliations
- National Institute of Mental Health (US)
- University Hospitals of Cleveland (US)
- Venue
- Neuropsychopharmacology
- Published
- 1993-08
- Volume
- 9
- Issue
- 1
- Pages
- 67-75
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2012245779
- Cited by
- 697
- References
- 34
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 2 · 2023: 5 · 2022: 10 · 2021: 14 · 2020: 12 · 2019: 10 · 2018: 8 · 2017: 13 · 2016: 19 · 2015: 22 · 2014: 26 · 2013: 19 · 2012: 30
- FWCI
- 21.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- schizophrenia, animal models of schizophrenia, ventral hippocampus, ibotenic acid, dopamine dysregulation, haloperidol
- MeSH terms
- Animals, Animals, Newborn, Dextroamphetamine, Disease Models, Animal, Female, Haloperidol, Hippocampus, Ibotenic Acid, Motor Activity, Pregnancy, Schizophrenia, Stress, Psychological, Swimming, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review